"outcomeId","cohortId","modelSettingsId","analysisId","devDatabase","populationSettingId","modelSettingId","covariateSettingId","modelSettingName","addExposureDaysToStart","riskWindowStart","addExposureDaysToEnd","riskWindowEnd","plpDataFolder","studyPopFile","plpResultFolder","cohortName","outcomeName"
1,3,1,1,"Optum claims",1,1,1,"Lasso Logistic Regression",0,1,0,365,"T:/atlasResults/testingDocResults/PlpData_L1_T3","T:/atlasResults/testingDocResults/StudyPop_L1_T3_O1.rds","T:/atlasResults/testingDocResults/Analysis_1","New users of ACE inhibitors as first-line monotherapy for hypertension","Acute myocardial infarction events"
1,3,2,5,"Optum claims",1,2,1,"Random forest",0,1,0,365,"T:/atlasResults/testingDocResults/PlpData_L1_T3","T:/atlasResults/testingDocResults/StudyPop_L1_T3_O1.rds","T:/atlasResults/testingDocResults/Analysis_5","New users of ACE inhibitors as first-line monotherapy for hypertension","Acute myocardial infarction events"
1,4,1,2,"Optum claims",1,1,1,"Lasso Logistic Regression",0,1,0,365,"T:/atlasResults/testingDocResults/PlpData_L1_T4","T:/atlasResults/testingDocResults/StudyPop_L1_T4_O1.rds","T:/atlasResults/testingDocResults/Analysis_2","New users of Thiazide-like diuretics as first-line monotherapy for hypertension","Acute myocardial infarction events"
1,4,2,6,"Optum claims",1,2,1,"Random forest",0,1,0,365,"T:/atlasResults/testingDocResults/PlpData_L1_T4","T:/atlasResults/testingDocResults/StudyPop_L1_T4_O1.rds","T:/atlasResults/testingDocResults/Analysis_6","New users of Thiazide-like diuretics as first-line monotherapy for hypertension","Acute myocardial infarction events"
2,3,1,3,"Optum claims",1,1,1,"Lasso Logistic Regression",0,1,0,365,"T:/atlasResults/testingDocResults/PlpData_L1_T3","T:/atlasResults/testingDocResults/StudyPop_L1_T3_O2.rds","T:/atlasResults/testingDocResults/Analysis_3","New users of ACE inhibitors as first-line monotherapy for hypertension","Angioedema events"
2,3,2,7,"Optum claims",1,2,1,"Random forest",0,1,0,365,"T:/atlasResults/testingDocResults/PlpData_L1_T3","T:/atlasResults/testingDocResults/StudyPop_L1_T3_O2.rds","T:/atlasResults/testingDocResults/Analysis_7","New users of ACE inhibitors as first-line monotherapy for hypertension","Angioedema events"
2,4,1,4,"Optum claims",1,1,1,"Lasso Logistic Regression",0,1,0,365,"T:/atlasResults/testingDocResults/PlpData_L1_T4","T:/atlasResults/testingDocResults/StudyPop_L1_T4_O2.rds","T:/atlasResults/testingDocResults/Analysis_4","New users of Thiazide-like diuretics as first-line monotherapy for hypertension","Angioedema events"
2,4,2,8,"Optum claims",1,2,1,"Random forest",0,1,0,365,"T:/atlasResults/testingDocResults/PlpData_L1_T4","T:/atlasResults/testingDocResults/StudyPop_L1_T4_O2.rds","T:/atlasResults/testingDocResults/Analysis_8","New users of Thiazide-like diuretics as first-line monotherapy for hypertension","Angioedema events"
